 |
|
Elaboration on Premorbid Intellectual Performance in Schizophrenia
Premorbid Intellectual Decline and Risk for Schizophrenia
Abraham Reichenberg, PhD;
Mark Weiser, MD;
Michael A. Rapp, MD, PhD;
Jonathan Rabinowitz, PhD;
Asaf Caspi, MD;
James Schmeidler, PhD;
Haim Y. Knobler, MD;
Gad Lubin, MD;
Daniela Nahon, MA;
Philip D. Harvey, PhD;
Michael Davidson, MD
Arch Gen Psychiatry. 2005;62:1297-1304.
Context Consistent evidence indicates that some, but not most, patients with schizophrenia have below-average intelligence years before they manifest psychosis. However, it is not clear whether this below-average premorbid intelligence is stable or progressive.
Objective To examine whether increased risk for schizophrenia is associated with declining intellectual performance from childhood through adolescence.
Design Historical cohort study of an entire population using record linkage for psychiatric hospitalization during an 8- to 17-year follow-up period.
Setting Mandatory assessment by the draft board of Israeli conscripts.
Participants Population-based cohort of 555 326 adolescents born in Israel. Data were available on 4 intelligence subtests as well as on reading and spelling abilities and on behavioral and psychosocial variables. A regression-based approach was used to assess the discrepancy between actual IQ at age 17 years and estimated IQ during childhood based on reading and spelling abilities.
Main Outcome Measures Hospitalization for schizophrenia (as per the International Statistical Classification of Diseases, 10th Revision criteria).
Results Lower-than-expected IQ at age 17 years was associated with increased risk for later hospitalization for schizophrenia. Results were held after controlling for potential confounders. For 75% of patients with schizophrenia with low actual IQ (<85) at age 17 years and for 23% of patients with actual IQ within the normal range ( 85), actual IQ was 10 or more points lower than expected. Lower-than-expected IQ was not associated with bipolar disorder or with depression or anxiety disorder.
Conclusions Indirect evidence suggests that intellectual deterioration from childhood through adolescence is associated with increased risk for schizophrenia. Despite within-normal-range premorbid IQ scores, apparently healthy adolescents who will later manifest schizophrenia nevertheless have intellectual decline.
Author Affiliations: Departments of Psychiatry (Drs Reichenberg, Rapp, Schmeidler, Harvey, and Davidson) and Biomathematical Science (Dr Schmeidler), Mount Sinai School of Medicine, New York, NY; Department of Psychiatry, Chaim Sheba Medical Center, Tel Hashomer, Israel (Drs Weiser, Caspi, and Davidson); School of Social Work, Bar Ilan University, Ramat Gan, Israel (Dr Rabinowitz); Medical Corps, Israel Defense Forces, Tel Hashomer (Drs Knobler and Lubin); and Ministry of Health, Jerusalem, Israel (Ms Nahon).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Premorbid IQ in Schizophrenia: A Meta-Analytic Review
Woodberry et al.
Am. J. Psychiatry 2008;165:579-587.
ABSTRACT
| FULL TEXT
Cognition in Young Schizophrenia Outpatients: Comparison of First-Episode With Multiepisode Patients
Braw et al.
Schizophr Bull 2008;34:544-554.
ABSTRACT
| FULL TEXT
The Maudsley Early Onset Schizophrenia Study: Cognitive Function Over a 4-Year Follow-Up Period
Frangou et al.
Schizophr Bull 2008;34:52-59.
ABSTRACT
| FULL TEXT
Cognitive decline following psychosis onset: Data from the PACE clinic
WOOD et al.
Br. J. Psychiatry 2007;191:s52-s57.
ABSTRACT
| FULL TEXT
Childhood cognitive performance and risk of generalized anxiety disorder
Martin et al.
Int J Epidemiol 2007;36:769-775.
ABSTRACT
| FULL TEXT
How Should DSM-V Criteria for Schizophrenia Include Cognitive Impairment?
Keefe and Fenton
Schizophr Bull 2007;33:912-920.
ABSTRACT
| FULL TEXT
Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial
Keefe et al.
Arch Gen Psychiatry 2007;64:633-647.
ABSTRACT
| FULL TEXT
Barriers to the Appropriate Clinical Use of Medications That Improve the Cognitive Deficits of Schizophrenia
Bromley
Psychiatr. Serv. 2007;58:475-481.
ABSTRACT
| FULL TEXT
|
